Back to top

Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva

Moderna stock ($MRNA) fell 1.5% to $55.39 on Thursday despite getting big news from health rules makers. The Food and Drug Administration approved ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Moderna, Inc. (MRNA)